Fertility & Maternal Health Drugs Advisory Cmte.
Executive Summary
Meeting Dec. 18-19 to discuss three drugs: (1) Metrodin (Serono's urofollitropin) for ovulation induction in polycystic ovarian disease, (2) Pergonal (Serono's menotropins) for follicular stimulation for in vitro fertilization on Dec. 18, and (3) Estraderm (TTS) for postmenopausal replacement therapy on Dec. 19. Meeting will be held at the Natl. Institutes of Health, Bldg. 31C, conference room 6 at 9 AM.
Meeting Dec. 18-19 to discuss three drugs: (1) Metrodin
(Serono's urofollitropin) for ovulation induction in polycystic
ovarian disease, (2) Pergonal (Serono's menotropins) for
follicular stimulation for in vitro fertilization on Dec.
18, and (3) Estraderm (TTS) for postmenopausal replacement
therapy on Dec. 19. Meeting will be held at the Natl. Institutes of
Health, Bldg. 31C, conference room 6 at 9 AM. |